Liver transplantation for hereditary tyrosinemia: the Quebec experience.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  American Journal of Human Genetics

• Publication date

  1990-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 2378360PMCID PMC1683709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurologic crises in hereditary tyrosinemia.

  1990cited by this paper
• Visceral pathology of hereditary tyrosinemia type I.

  1990cited by this paper
• Kidney transplantation.

  1989cited by this paper
• Tyrosinaemia Type I: Orthotopic Liver Transplantation as the Only Definitive Answer to a Metabolic as well as an Oncological Problem

  1989cited by this paper
• Amplification of the nephrotoxic effect of cyclosporine by preexistent chronic histological lesions in the kidney.

  1989cited by this paper
• SERIAL DECREASE IN GLOMERULAR FILTRATION RATE IN LONG‐TERM PEDIATRIC LIVER TRANSPLANTATION SURVIVORS TREATED WITH CYCLOSPORINE

  1989cited by this paper
• Liver transplantation for metabolic disease of the liver.

  1988cited by this paper
• Hepatic regenerating nodules in hereditary tyrosinemia.

  1987cited by this paper
• Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation.

  1987cited by this paper
• Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma.

  1985cited by this paper
• Persistent succinylacetone excretion after liver transplantation in a patient with hereditary tyrosinaemia type I

  1985cited by this paper
• Growth retardation and renal osteodystrophy in children with chronic renal failure.

  1983cited by this paper
• The occurrence of hepatoma in the chronic form of hereditary tyrosinemia.

  1976cited by this paper
• Experience with 37 infants with tyrosinemia.

  1967cited by this paper

• NTBC dosing and outcomes in hereditary tyrosinemia type 1: insights from a representative human model and 99 patients

  2025cites this paper
• Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1: Consensus group recommendations from the German‐speaking countries

  2024cites this paper
• Abnormalities of Hepatic Protein Metabolism

  2021cites this paper
• Living‐donor liver transplantation for children with tyrosinemia type I

  2020influential citation
• Successive Drug Therapy for a Very Rare Autosomal Diseases

  2019cites this paper
• Developmental and Inherited Liver Disease

  2018cites this paper
• NTBC and Correction of Renal Dysfunction.

  2017cites this paper
• Case of hepatocellular carcinoma in a patient with hereditary tyrosinemia in the post-newborn screening era

  2017cites this paper
• Hereditary Tyrosinemia

  2017cites this paper
• Liver Transplantation for Monogenic Metabolic Diseases Involving the Kidney

  2017cites this paper
• The Liver in Tyrosinemia Type I: Clinical Management and Course in Quebec.

  2017cites this paper
• Remaining Challenges in the Treatment of Tyrosinemia from the Clinician's Viewpoint.

  2017cites this paper
• Biochemical and Clinical Aspects of Hereditary Tyrosinemia Type 1.

  2017cites this paper
• Chapter 27 – Transplantation for Metabolic Disease in Children

  2015cites this paper
• Early effect of NTBC on renal tubular dysfunction in hereditary tyrosinemia type 1.

  2014cites this paper
• Pediatric Fanconi Syndrome

  2014cites this paper
• Early nitisinone treatment reduces the need for liver transplantation in children with tyrosinaemia type 1 and improves post-transplant renal function

  2014cites this paper
• Stoffwechselerkrankungen

  2013cites this paper
• Plasma succinylacetone is persistently raised after liver transplantation in tyrosinaemia type 1

  2013cites this paper
• Clinical and Para Clinical Findings in the Children with Tyrosinemia Referring for Liver Transplantation

  2013cites this paper
• Current management options for tyrosinemia

  2013cites this paper
• Inherited Disorders of the Renal Tubule

  2012cites this paper
• 4 – Genetic and metabolic liver disease

  2012cites this paper
• Hepatorenal tyrosinemia

  2012cites this paper
• Hepatorenal tyrosinemia/fumarylacetoacetate hydrolase deficiency

  2011cites this paper
• Paediatric liver transplantation for metabolic disorders. Part 2: Metabolic disorders with liver lesions.

  2011cites this paper
• Monitoring tyrosinaemia type I: Blood spot test for nitisinone (NTBC).

  2011cites this paper
• Other Inherited Metabolic Disorders of the Liver

  2010cites this paper
• Indications for combined liver and kidney transplantation in children

  2009cites this paper
• Metabolic Disease and Hepatocellular Carcinoma

  2009cites this paper
• Renal tubular function in children with tyrosinaemia type I treated with nitisinone

  2008cites this paper
• Hereditary Tyrosinemia Type 1: Strong Association with Haplotype 6 in French Canadians Permits Simple Carrier Detection and Prenatal Diagnosis

  2007cites this paper
• The efficacy of liver transplantation in malignant liver tumors associated with tyrosinemia: Clinical and laboratory findings of five cases

  2006influential citation
• Evaluation of dichloroacetate treatment in a murine model of hereditary tyrosinemia type 1.

  2006cites this paper
• 24 – Liver Transplantation for Metabolic Disease

  2005cites this paper
• Orthotopic liver transplantation in liver-based metabolic disorders

  2005cites this paper
• ARCHIVES OF DISEASE IN CHILDHOOD

  2004cites this paper
• A Case of Tyrosinemia Type 1 with Cytomegalovirus Infection

  2004cites this paper
• ARCHIVES OF DISEASE IN CHILDHOOD

  2004cites this paper
• Tyrosinämie Typ I

  2004cites this paper
• Frequent mutation reversion inversely correlates with clinical severity in a genetic liver disease, hereditary tyrosinemia.

  2003cites this paper
• Two Cases of Acute Form of Tyrosinemia Type I

  2002cites this paper
• Acute liver failure in infancy: a 14-year experience of a pediatric liver transplantation center.

  2001cites this paper
• Tyrosinemia: A Review

  2001cites this paper
• Mechanistic Inferences from the Crystal Structure of Fumarylacetoacetate Hydrolase with a Bound Phosphorus-based Inhibitor*

  2001cites this paper
• Nutrition and Liver Disease

  2001cites this paper
• Liver transplantation. The pediatric challenge.

  2000cites this paper
• In vivo selection of hepatocytes transduced with adeno-associated viral vectors.

  2000cites this paper
• Hereditary tyrosinaemia type I: from basics to progress in treatment

  2000cites this paper
• Hepatocellular carcinoma despite long-term survival in chronic tyrosinaemia I

  2000cites this paper
• Évolution favorable sous traitement par NTBC de l'insuffisance hépatique aiguë révélatrice de la tyrosinémie héréditaire de type I

  1999cites this paper
• [Favorable outcome of treatment with NTBC of acute liver insufficiency disclosing hereditary tyrosinemia type I].

  1999cites this paper
• Indications and outcome of liver transplantation in tyrosinaemia type 1

  1999cites this paper
• Nontransplant alternatives for the treatment of patients with metabolic disease.

  1998cites this paper
• Therapeutic trials in the murine model of hereditary tyrosinaemia type I: A progress report

  1998cites this paper
• Ex Vivo Hepatic Gene Therapy of a Mouse Model of Hereditary Tyrosinemia Type I

  1998cites this paper
• Adenovims-Mediat ed G en e T herap y in a M ous e M ode l of Hereditary Tyrosinemia Typ e I

  1997cites this paper
• Adenovirus-Mediated Gene Therapy in a Mouse Model of Hereditary Tyrosinemia Type I

  1997cites this paper
• Successful combined liver and kidney transplantation in children despite HLA mismatching.

  1996cites this paper
• The Nephropathy of Type I Tyrosinemia after Liver Transplantation

  1996cites this paper
• Imaging features of type 1 hereditary tyrosinemia: a review of 30 patients

  1996cites this paper
• Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I

  1996cites this paper
• Tyrosinemia: the Quebec experience.

  1996cites this paper
• Pediatric case of the day. Hepatorenal tyrosinemia (tyrosinemia type I).

  1996cites this paper
• Pediatric gastroenterology. Update on metabolic liver disease.

  1996cites this paper
• UPDATE ON METABOLIC LIVER DISEASE

  1996cites this paper
• Liver transplantation for metabolic disorders

  1995cites this paper
• Single‐center experience of combined liver and kidney transplantation

  1995cites this paper
• Heterozygosity for an exon 12 splicing mutation and a W234G missense mutation in an American child with chronic tyrosinemia type 1

  1995cites this paper
• A mouse model for human hereditary tyrosinemia I.

  1994cites this paper
• Hereditary tyrosinemia type I: A new clinical classification with difference in prognosis on dietary treatment

  1994cites this paper
• Inborn errors of metabolism associated with disordered liver function or hepatomegaly

  1994cites this paper
• Structural organization and analysis of the human fumarylacetoacetate hydrolase gene in tyrosinemia type I.

  1994cites this paper
• A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I.

  1994cites this paper
• Cyclosporine kinetics in pediatric liver transplant recipients: impact of dose fractionation on true glomerular filtration rate.

  1994cites this paper
• Two novel mutations involved in hereditary tyrosinemia type I.

  1994cites this paper
• Hereditary tyrosinemia type I: strong association with haplotype 6 in French Canadians permits simple carrier detection and prenatal diagnosis.

  1994cites this paper
• Structure of the human 4-hydroxyphenylpyruvic acid dioxygenase gene (HPD).

  1994cites this paper
• Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, type I

  1993cites this paper
• Localization of cells in the rat brain expressing fumarylacetoacetate hydrolase, the deficient enzyme in hereditary tyrosinemia type 1.

  1993cites this paper
• SURGICAL AND METABOLIC ASPECTS OF LIVER TRANSPLANTATION FOR TYROSINEMIA1

  1993cites this paper
• Liver transplantation.

  1992cites this paper
• Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient.

  1992cites this paper
• Improvement in true glomerular filtration rate after cyclosporine fractionation in pediatric liver transplant recipients.

  1991cites this paper
• Liver transplantation.

  1990cites this paper
• rese-Herediter Trozinemi Tip 1 ve Canl ı Vericili Karaci ğ er Nakli: Zamanlama-Hasta Seçimi-Komplikasyonlar Hereditary Tyrosinemia Type 1 and Living Donor Liver Transplantation: Timing-Patient Selection-Complications

  year unknowncites this paper